Literature DB >> 10929952

Obstetric risks and vertical transmission of hepatitis C virus infection in pregnancy.

P Hillemanns1, C Dannecker, R Kimmig, U Hasbargen.   

Abstract

BACKGROUND: Reports of obstetric complications of mothers infected with hepatitis C virus (HCV) are limited and the risk of mother-to-infant transmission varies widely. We assessed the course of pregnancy in HCV-infected women and the rate of vertical transmission.
METHODS: Between October 1992 and December 1996, 3712 pregnant patients of the university hospital Grosshadern Munich, Germany, were screened for anti-HCV and analyzed for HCV-RNA by polymerase chain reaction. Clinical and biochemical parameters were monitored. Children born to HCV-positive women were followed up at 6, 12 and 18 month intervals and screened for anti-HCV and HCV-RNA.
RESULTS: Thirteen (42%) of 31 anti-HCV positive patients had a cesarean section which was twice the rate of that in the HCV-negative group (p=0.004). None of the cesarean deliveries was due to complications directly caused by HCV infection. Nine (29%) of 31 anti-HCV positive women had preterm delivery compared to 19% in the anti-HCV negative patients, the difference being statistically not significant. Fetal outcome parameters such as APGAR score, umbilical pH and birth weight of HCV infected pregnancies were not impaired. All 29 babies tested for anti-HCV were seropositive after birth. Between 12 and 18 months of age, 10% of the infants still were anti-HCV positive, whereas only one baby was HCV-RNA positive beyond 12 months yielding a vertical transmission rate of 5% among HCV-RNA positive mothers.
CONCLUSION: Anti-HCV positive pregnancies have an increased risk of cesarean delivery, probably due to the high-risk collective of anti-HCV positive mothers. The mother-to-child transmission rate is low and linked to maternal HCV-RNA positivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10929952

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  9 in total

Review 1.  Hepatitis C in pregnancy.

Authors:  N Hadzić
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 2.  Viral hepatitis and pregnancy.

Authors:  Norah A Terrault; Miriam T Levy; Ka Wang Cheung; Gonzague Jourdain
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-12       Impact factor: 46.802

Review 3.  Hepatitis C in pregnancy.

Authors:  Grace L Su
Journal:  Curr Gastroenterol Rep       Date:  2005-02

Review 4.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

Review 5.  Hepatitis C virus infection in children coinfected with HIV: epidemiology and management.

Authors:  Massimo Resti; Chiara Azzari; Flavia Bortolotti
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  Hepatitis C and pregnancy.

Authors:  Annarosa Floreani
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

7.  Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden.

Authors:  Knut Stokkeland; Jonas Filip Ludvigsson; Rolf Hultcrantz; Anders Ekbom; Jonas Höijer; Matteo Bottai; Olof Stephansson
Journal:  Eur J Epidemiol       Date:  2017-05-26       Impact factor: 8.082

8.  Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients.

Authors:  Youyin Choy; Lisa Gittens-Williams; Joseph Apuzzio; Joan Skurnick; Carl Zollicoffer; Peter G McGovern
Journal:  Infect Dis Obstet Gynecol       Date:  2003

Review 9.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Authors:  Susan J M Hahné; Irene K Veldhuijzen; Lucas Wiessing; Tek-Ang Lim; Mika Salminen; Marita van de Laar
Journal:  BMC Infect Dis       Date:  2013-04-18       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.